Abstract
AbstractThe purpose of this study was to examine a secondary source of data and attempt to identify physician and patient related factors which are associated with the prescribing of new prescription drugs. Eight drugs introduced to the general market between January, 1977 and December, 1980 were selected as “new drugs” for study. Study drug utilization was compared to that of established drugs of the same therapeutic categories to determine whether there were significant differences in the relative frequencies of use between the new drugs and the established drugs with respect to physician and patient characteristics. The major conclusions of the study were 1 that treatment variables (the drug(s) examined, patient’s disease and the treatment setting) are important considerations in establishing an association between prescribing behavior and physician and patient characteristics; (2) the use of secondary data sources to study these associations can serve a limited but useful function in an overall, compr...
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Clinical Research Practices and Drug Regulatory Affairs
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
